NCT04496635 (CCR-VINCat) is a NA clinical trial of Implementation of a bundle of care in Colon Rectal Cancer, sponsored by Hospital de Granollers.

Who is sponsoring NCT04496635?

NCT04496635 is sponsored by Hospital de Granollers.

What drugs are being tested in NCT04496635?

Interventions in NCT04496635: Implementation of a bundle of care.

What condition does NCT04496635 study?

NCT04496635 studies Colon Rectal Cancer, Surgical Site Infection.

Is NCT04496635 still recruiting?

NCT04496635 is currently status unknown. Last updated 22 August 2023.

Last reviewed 2023-08-22 · How we verify

NCT04496635: CCR-VINCat

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Surveillance and Implementation of a Bundle of Care to Reduce Surgical Site Infection in Colorectal Surgery (CCR-VINCat)

Status unknown NA Last updated 22 August 2023

What this trial tests

NA trial testing Implementation of a bundle of care in Colon Rectal Cancer in 60,000 participants. Status unknown.

Timeline

1 January 2007

Primary endpoint
30 November 2025

30 December 2025

Quick facts

Lead sponsor	Hospital de Granollers
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	sequential
Masking	none
Primary purpose	prevention
Enrollment	60,000
Start date	1 January 2007
Primary completion	30 November 2025
Estimated completion	30 December 2025
Sites	1 location across Spain

Drugs / interventions tested

Implementation of a bundle of care

Conditions studied

Colon Rectal Cancer — all drugs for Colon Rectal Cancer →
Surgical Site Infection — all drugs for Surgical Site Infection →

Sponsor

Hospital de Granollers

Who can join

Eligibility, any sex, with Colon Rectal Cancer or Surgical Site Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Nosocomial Infection Surveillance Program in Catalonia (VINCat) monitors surgical site infection (SSI) in elective colorectal surgery since 2007 in 55 public and private acute care hospitals. These hospitals perform active and prospective standardized surveillance of elective colorectal resections. Post-discharge surveillance is mandatory at least up to 30 days after surgery. Hospitals are classified according to their size into three groups: \>500 hospital beds; 200-500 beds; \<200 beds. Aim. To examine the effect on SSI rate of a specific preventative bundle in elective colorectal surgery. Methods. Pragmatic study using VINCat prospective colorectal database from 2007 to 2018. In 2016, a bundle of six preventative measures was recommended to the VINCat hospitals. To compare the results of SSI before (baseline phase, BP) and after the bundle implementation (implementation phase, IP) a logistic regression model has been established. The results will be shown as Odds Ratio (OR) and the corresponding confidence intervalsCI95. The significance level will be fixed at 5% (P \< 0.05).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Implementation of a bundle of care

Trials testing the same drug.

NCT06244836 — Comparison of Two Bundles of Care to Reduce Surgical Site Infection in Colorectal Surgery (CCR-VINCat 2) · NA · completed

Other recruiting trials for Colon Rectal Cancer

Currently open trials in the same condition.

NCT06028724 — A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Meth · recruiting
NCT05750953 — Nurse-assisted Intervention "eHealth@ Hospital -2-home" · NA · active not recruiting
NCT04147078 — Personalized DC Vaccine for Postoperative Cancer · Phase 1 · recruiting

Other Hospital de Granollers trials

Trials by the same sponsor.

NCT07486206 — Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial · NA · recruiting
NCT07482917 — Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial · NA · recruiting
NCT07130656 — AI Algorithm for Surveillance of Deep Surgical Site Infections After Elective Colorectal Surgery. · recruiting
NCT06626399 — ChatGPT-4 for Surgical Site Infection Detection From Electronic Health Records After Colorectal Surgery. · recruiting
NCT06556017 — Assessment of the Efficacy of ChatGPT in Detecting Surgical Site Infections Following Elective Colorectal Surgery · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04496635 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital de Granollers
Last refreshed: 22 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04496635.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing